(Q48465761)

11 February 2018

title

Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. (English)

1 reference

11 February 2018

0 references

1 reference

Corinne Pellieux

1

1 reference

11 February 2018

Ellen Aasum

2

1 reference

11 February 2018

Terje S Larsen

3

1 reference

11 February 2018

Christophe Montessuit

4

1 reference

11 February 2018

Irène Papageorgiou

5

1 reference

11 February 2018

Thierry Pedrazzini

6

1 reference

11 February 2018

René Lerch

7

1 reference

11 February 2018

publication date

21 July 2006

1 reference

11 February 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

11 February 2018

volume

41

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

459-466

1 reference

11 February 2018

Does load-induced ventricular hypertrophy progress to systolic heart failure?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Fatty acid oxidation enzyme gene expression is downregulated in the failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Nuclear receptor signaling and cardiac energetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Saturated glucose uptake capacity and impaired fatty acid oxidation in hypertensive hearts before development of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

The renin-angiotensin system and experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Age-linked changes in the activity of enzymes of the tricarboxylate cycle and lipid oxidation, and of carnitine content, in muscles of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Myocardial substrate metabolism in the normal and failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Peroxisome proliferator-activated receptors and cardiovascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

10.1016/J.YJMCC.2006.06.004

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018